Matches in Nanopublications for { ?s ?p "[PAR2 is a primary mediator of RhoA activation, signaling, and cytoskeletal reorganization when expressed on LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP103747.RA900ruXAOSdBYvosvHWGsJphAuOubZkphg_iq8H2D0vo130_assertion description "[PAR2 is a primary mediator of RhoA activation, signaling, and cytoskeletal reorganization when expressed on LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP103747.RA900ruXAOSdBYvosvHWGsJphAuOubZkphg_iq8H2D0vo130_provenance.
- assertion description "[PAR2 is a primary mediator of RhoA activation, signaling, and cytoskeletal reorganization when expressed on LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP166967.RAVTux02CvaFLStKLTmwUvAZPE0fQ_2q5DXu0HSRRoijM130_assertion description "[PAR2 is a primary mediator of RhoA activation, signaling, and cytoskeletal reorganization when expressed on LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP166967.RAVTux02CvaFLStKLTmwUvAZPE0fQ_2q5DXu0HSRRoijM130_provenance.
- NP197818.RAunJXitJWZEMhMgfJgn1rvBj2xd993yM9sorED0o9TN0130_assertion description "[PAR2 is a primary mediator of RhoA activation, signaling, and cytoskeletal reorganization when expressed on LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197818.RAunJXitJWZEMhMgfJgn1rvBj2xd993yM9sorED0o9TN0130_provenance.